Aduhelm raises questions about financial conflicts among patient groupsAduhelm raises questions about financial conflicts among patient groupsAduhelm raises questions about financial conflicts among patient groups

Aduhelm raises questions about financial conflicts among patient groups

Critics say patient advocacy groups should disclose their financial ties with companies when lobbying for the approval of new medications.

from Section Page News - Modern Healthcare https://ift.tt/35N3fmV